ArticleNature cancer2021

Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma.

Wenjuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.